Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulin Toxin vs ISDN Ointment for Anal Fissure
NCT00827736Phase 4Completed
- Sponsor
- OLVG
- Start
- Jun 2002
- Primary completion
- Mar 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Onabotulinumtoxina + hydrogel in anal fissure, sponsored by OLVG. Started Jun 2002; status: completed.
02
Drugs
Onabotulinumtoxina + hydrogel
03
Conditions
anal fissure
Beyond the preview
Go deeper on NCT00827736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00827736.